APHIS offers annual competitive funding opportunities to support high value projects that target the priority topics that are identified through consultation with stakeholders and the NADPRP Consultation Board.
There are currently no open NADPRP funding opportunities. APHIS anticipates announcing the next annual NADPRP funding opportunity in June 2022 and an additional funding opportunity for Tribal partners in fall 2022.
To date, APHIS has invested $22.1 million to support 120 new animal disease prevention and preparedness projects with State, industry, and university partners. Details about the funded projects are provided below.
In 2021, APHIS provided $7.6 million for 35 projects focused on (1) developing vaccination plans for FAD outbreaks, (2) supporting animal movement decisions in an FAD outbreak, or (3) delivering outreach and education on animal disease preparedness and response topics to targeted audiences.
APHIS also provide an additional $4.3 million for 7 projects aimed at developing and evaluating point-of-care diagnostic tests for foreign animal diseases. These projects were jointly supported by NADPRP and the National Animal Health Laboratory Network.
In 2020, APHIS provided $9.3 million for 46 projects focused on (1) improving capabilities and capacity for rapid and large-scale animal depopulation and/or carcass disposal during a high-consequence animal disease outbreak response, or (2) enhancing U.S. livestock biosecurity.
The NADPRP Consultation Board provides stakeholder input to APHIS to guide the NADPRP program and assist in identifying funding priority topics. The Board is comprised of 14 members nominated by the United States Animal Health Association to represent State animal health officials, livestock industry organizations, and academia. The Board also includes a representative nominated by USDA’s Agricultural Research Service and a Tribal nation representative nominated by the APHIS Office of the Tribal Liaison. As directed in the 2018 Farm Bill, this consultation with NADPRP eligible entities is exempt from the Federal Advisory Committee Act.